Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-20

Clinical Trial Update: Suvorexant for Treatment of AUD and PTSD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial is evaluating suvorexant for treatment of alcohol use disorder and post-traumatic stress disorder and is currently recruiting. Insomnia i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suvorexant (suvorexant)

Snippet

Sponsor: Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | Conditions: Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD) | Phase 2 | Status: RECRUITING